Medidata’s clinical protocol authoring and trial design tool takes top honors in clinical trial and research category.
New York, NY-May 2, 2008-Medidata Solutions (www.mdsol.com), a global provider of clinical trial technology, today announced that Medidata Designer™ has been selected as the winner of Bio-IT World magazine’s Best of Show award in the Clinical Trials and Research category. Medidata Designer was chosen from a group of more than 30 companies in the clinical technology space and was honored at the Bio-IT World Conference and Expo, held April 28–30, 2008, in Boston, MA.
“Medidata Designer emerged as the clear leader in the Clinical Trials and Research category in this year?s competition,” said Stephen Fogelson, president of Develotron LLC and one of the judges for the Best of Show awards. “While we received and reviewed a number of impressive submissions, Medidata Designer stood out from the rest due to its ability to bring significant value to clinical researchers by eliminating inconsistency errors and improving the overall quality of clinical protocols.”
A top recognition in the life sciences space, this award demonstrates Medidata’s commitment to advancing clinical trial solutions through innovative technology. As an electronic protocol authoring tool, Medidata Designer captures both the textual description of a study as well as a structured, electronic model of the trial specifications that can be leveraged downstream in clinical and operational study management and design. The product brings better quality, consistency and control to the protocol authoring process and delivers tangible benefits to medical writers, clinicians, and statisticians who author the protocol and other associated study documents. Furthermore, Medidata Designer can automatically configure other clinical trial systems-such as electronic data capture (EDC), clinical trial management (CTMS), electronic patient reported outcomes (ePRO), data analysis, and electronic data submissions-ensuring an automated environment for consistent, shared clinical and operational requirements.
“We are thrilled to have been selected as a Best of Show award winner and recognized as one of the most innovative clinical trial technology organizations in the industry,” said Ed Seguine, general manager of trial planning solutions at Medidata Solutions. “The selection of Medidata Designer as a Best of Show winner emphasizes our development team’s dedication to providing life science companies with the tools they need to drive significant efficiencies across the clinical trial process and for all members of the clinical research team.”
The Best of Show awards program is judged by a team of Bio-IT World magazine editors and leading industry experts and spotlights new products that demonstrate exceptional technology innovation across the life sciences research, discovery, and clinical trials process. Winners were chosen among entries submitted from leading bio-IT vendors exhibiting at the annual conference and expo, based on the products’ technical merit, functionality, and innovation. Finalists were chosen from seven categories, including Clinical Trials and Research, Basic Research/R&D, Drug Discovery & Development, Translational & Personalized Medicine, Business & Economic Development, IT Infrastructure/Knowledge Management, and Chemistry & Compounds.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Beyond the Molecule: How Human-Centered Design Unlocks AI's Promise in Pharma
June 23rd 2025How human-centered AI that is focused on customer, user, and employee experience can drive real transformation in clinical trials and beyond by aligning intelligent technologies with the people who use them.
2025 DIA Annual Meeting: Why AI and Automation Are Set to Become the New Normal in Clinical Research
June 20th 2025Peter Ronco, CEO, Emmes, shares his long-term vision for artificial intelligence in clinical research, from making automation routine to improving drug discovery, transforming regulatory oversight, reducing animal testing, and promoting ethical, equitable data use worldwide.